299.
Sympathetic activity in obese subjects with and without obstructive sleep
apnea / K. Narkiewicz [et al.] // Circulation. – 1998. – Vol. 98. – P. 772-776.
300.
Sympathoadrenal activity in human obesity: heterogeneity of findings since
1980 / J. B. Young [et al.] // Int. J. Obes. Relat. Metab. Disord. – 1992. – Vol. 16.
– P. 959-967.
301.
Szabo B. Imidazoline antihypertensive drugs: a critical review on their
mechanism of action / B. Szabo // Pharmacol. Ther. – 2002. – Vol. 93. – P. 1-35.
302.
The European trial on reduction of cardiac events with perindopril in stable
coronary artery disease (EUROPA) / K. M.
et al.] //
– 1998. –
Vol. 19, – P. 52-555.
303.
The Framingham Heart Study – 50 years of research success [Электронный
ресурс]. – Режим доступа: http:
304.
The Munster Heart Study (PROCAM). Results of follow-up at 8 years / G.
Assmann [et al.] // Eur. Heart J. – 1998. – Vol. 19. – Р. 2-11.
305.
The role of serotonin in preeclamptic hypertension / C. Hutter [et al.] // Int. J.
Obstet. Anesth. – 1996. – Vol. 5, № 2. – P. 108-114.
306.
The role of the sympathetic nervous system in obesity-related hypertension /
A. A. da Silva [et al.] // Curr. Hypertens. Rep. – 2009. – Vol. 11, № 3. – P. 206-
211.
307.
The study on cognition and prognosis in the elderly (SCOPE). Principal results
of arandomised double-blind intervention trial / H. Lithell [et al.] // J. Hypertens. –
2003. – Vol. 21. – P. 875-886.
308.
The underlying mechanisms for development of hypertension in the metabolic
syndrome / H. Yanai [et al.] // Nutr. J. – 2008. – Vol. 7. – P. 10.
309.
Touyz R. M. Oxidative stress and vascular damage in protective hypertension /
R. M. Touyz // Curr. Hypertens. Rep. – 2000. – Vol. 2. – P. 98-105.
310.
Traub O. Laminar shear stress. Mechanisms by witch endothelial cells
transduce an atheroprotective force / O. Traub, B. C. Berk // Arterioscler.
Thromb. Vasc. Biol. – 1998. – Vol. 18. – P. 677-685.
